Growth Metrics

Sarepta Therapeutics (SRPT) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -239.69%
Dec 31, 2025 -58.60%
Sep 30, 2025 621.49%
Jun 30, 2025 111.06%
Mar 31, 2025 -138.11%
Dec 31, 2024 693.14%
Sep 30, 2024 -30.75%
Jun 30, 2024 -145.03%
Mar 31, 2024 439.97%
Dec 31, 2023 69.44%
Sep 30, 2023 -317.91%
Jun 30, 2023 673.57%
Mar 31, 2023 27.52%
Dec 31, 2022 -48.76%
Sep 30, 2022 106.59%
Jun 30, 2022 63.10%
Mar 31, 2022 -30,393.09%
Dec 31, 2021 -112.72%
Sep 30, 2021 -93.69%
Jun 30, 2021 104.93%
Mar 31, 2021 226.45%
Dec 31, 2020 -329.11%
Sep 30, 2020 258.00%
Jun 30, 2020 -93.58%
Mar 31, 2020 -203.51%
Dec 31, 2019 195.11%
Sep 30, 2019 -111.79%
Jun 30, 2019 12.68%
Mar 31, 2019 156.88%
Dec 31, 2018 -274.98%
Sep 30, 2018 -15.08%
Jun 30, 2018 -286.34%
Mar 31, 2018 97.11%
Dec 31, 2017 -495.12%
Sep 30, 2017 723.06%
Jun 30, 2017 -109.55%
Mar 31, 2017 205.64%
Dec 31, 2016 -2,044.19%
Sep 30, 2016 -87.05%
Jun 30, 2016 306.42%
Mar 31, 2016 127.82%
Dec 31, 2015 -325.08%
Sep 30, 2015 816.91%
Jun 30, 2015 -92.28%
Mar 31, 2015 -6.11%
Dec 31, 2014 327.24%
Sep 30, 2014 -613.97%
Jun 30, 2014 98.42%
Mar 31, 2014 -22,076.28%
Dec 31, 2013 50.98%
Sep 30, 2013 -15.42%
Jun 30, 2013 81.18%
Mar 31, 2013 -1,725.06%
Dec 31, 2012 -422.22%
Sep 30, 2012 78.63%
Jun 30, 2012 -44.66%
Mar 31, 2012 66.58%
Dec 31, 2011 -145.00%
Sep 30, 2011 63.01%
Jun 30, 2011 -157.44%
Mar 31, 2011 33.73%
Dec 31, 2010 -3.68%